Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4539_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
152 NON-SURGICAL RHINOPLASTY
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Figure 10.11.1 A 43-year-old woman with three previous surgeries. Both triangular cartilages collapsed due to an overresection,
Video 10.11.1 Evaluation of a 34-year-old patient with “mestizo” nose and lack of support in the nasal tip. Available at https://resource centre.routledge.com/books/9781032303444
and there is a similar situation in the septum and crus lateralis of both alars, with consequent ventilatory insuffi­ciency: (a-c) before and (d-f) after rhino-modeling.
Note: Page numbers in italic indicate a gure or diagram and page numbers in bold indicate a table on the corresponding page.
Index
A
acne, 59–60, 59– 60, 61, 71–72
OCT, and, 71 RCM, and, 72
aesthetic treatments, see nasal aesthetic
treatments alar retraction or collapse, 97 anatomy
deep anatomy, 27–30
bone, 30, 30 cartilage, 30–31, 30 –31 fat, 27–28, 28 innervation, 29, 29–30 muscles, 28–29, 28 skin, 27, 27 vascularization, 29, 29
surface anatomy, 21–24
introduction, 21 lines identifying specic points,
24, 24
nasal grid, 24, 24 nasal surrounding areas, 23, 23
nasal terminology, 21–23, 22 Asian cases, 139–141, 140 –141 assessment, see preoperative diagnosis autoimmune diseases
RCM, and, 75
B
basal cell carcinoma (BCC), 64–66, 64– 66 bone, 30, 30 botulinum toxin, 7–8
bunny lines, 7–8, 100 market, 13 sagging nasal tip, 8, 100 statistical analysis on treated patients and
stability of ller, 100
bunny lines
botulinum toxin, 7–8, 100
C
“camouage,” optical, 147 cartilage, 30–31, 30 –31 cheek and zygomatic arch 110–111 clinical aspects
clinical defects and the technical approach
equipment, 39, 39
framing technique, 39–40
patient preparation, 39
picture protocol, 40, 40–44
technical devices, introduction to,
35–39, 36–38
patient consultation, 45–46, 45
MD Codes, 46–47, 47 clinical cases
Asian cases, 139–141, 140 –141 long duration of HA llers in the nose,
161–162 , 161–162
nasal hump
dorsum approach, 165, 166 multiple approach, 163–164, 163–164
nasofrontal angle with ultrasound
correlation, 153–155, 153 –155
non-surgical rhinoplasty, 101–107,
102–107
long-term correction after ve years,
135, 135–138 proleplasty, 143–146, 143–146 rhino 4-point technique with llers of
different densities, 149–152,
150 –151
rhino-modeling in South America, 167, 168 Slavic cases, 147–148, 14 7–148 surgical rhinoplasty, 82–84, 82–84 tinkerbell tip lift technique, 157–159,
158 –159
clinical defects and the technical approach
equipment, 39, 39 framing technique, 39–40 patient preparation, 39 picture protocol, 40, 40–44 technical devices, introduction to, 35–39,
36–38
closed nasal labial angle nasal base
retrusion, 90
combined devices, 9 complications, 121–128, 122– 123, 125, 126, 127
classication of, 124–125 diagnosis and therapy of, 125–127
late occurring reactions, 126–127 vascular complications, 125–126
prevention, 122–124
computed tomography (CT), 75 consultation, patient, 45–46, 45
MD Codes, 46–47, 47
crooked nose deformity, 96 CT, see computed tomography
D
deep anatomy, 27–30, see also anatomy
bone, 30, 30 cartilage, 30–31, 30 –31 fat, 27–28, 28 innervation, 29, 29–30 muscles, 28–29, 28 skin, 27, 27 vascularization, 29, 29
deep glabella, 94 defects, clinical, see clinical defects and the
technical approach
dependent tip, 91 dermatitis, 62, 62 dermoscopy, 69
impetigo, and, 72 lichen planus, and, 73 psoriasis, and, 73 rosacea, and, 70 seborrheic dermatitis, and, 72
deviated nose, 95 devices, see technical devices diagnosis, see complications; preoperative
diagnosis D-O CT, see speckle-variance OCT dynamic OCT, see speckle-variance OCT
E
endoscopic diagnosis and instrumentation
tools, 54 ethnic features, 86–87, 86–87, see also Asian
cases; Slavic cases
leptorrhine nose, 87, 87 mesorrhine nose, 86, 86 platyrrhine nose, 86, 86
equipment, 39, 39
F
fat, 27–28, 28 brous papule (FP), 63, 63 framing technique, 39–40
G
grid, nasal, 24, 24
H
HA see hyaluronic acid (HA) llers herpes simplex virus (HSV), 58, 59, 70–71
dermoscopy, and, 71 LC-OCT, and, 71
RCM, and, 71 hidden columella nasal base retrusion 89 hyaluronic acid (HA) llers, 3–4, see also
non-surgical proleplasty; non­surgical rhinoplasty
complications, 121–128, 122– 123, 125,
126, 127
market, 11–12
I
impetigo 59, 72–72
dermoscopy, and, 72
RCM, and, 72 infective/inammatory conditions, 58 inammatory conditions, see infective/
inammatory conditions injectable proleplasty, 115–116 injection plan and procedure, 97–99 innervation, 29, 29–30
L
late occurring reactions, 126–127, see also
complications LC-OCT, see line-eld confocal optical
coherence tomography
153
154 INDEX
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
leptorrhine nose, 87, 87 lichen planus, 73
dermoscopy, and, 73 OCT, and, 74 RCM, and, 74
line-eld confocal optical coherence
tomography (LC-OCT), 69
active herpes infection, 71 lines identifying specic points, 24, 24 lips, 112–113 long duration of HA llers in the nose,
161–162 , 161–162
M
magnetic resonance imaging (MRI),
52–53, 52 malignant melanoma (MM), 66–67, 67 market
botulinum toxin, 13
hyaluronic acid (HA) llers, 11–12 MD Codes, 46–47, 47 mesorrhine nose, 86, 86 muscles, 28–29, 28
N
nasal aesthetic treatments
botulinum toxin, 7–8
bunny lines, 7–8 market, 13
sagging nasal tip, 8 combined devices, 9 hyaluronic acid (HA) llers, 3–4
market, 11–12 introduction, 1 social networks, impact of, 15–17
nasal base retrusion, 89 nasal boundaries, 87, 87 nasal grid, 24, 24, 87 nasal hump, 92
clinical cases, 163–164, 163–16 4, 165, 166
nasal surrounding areas, 23, 23 nasal terminology, 21–23, 22 na solabial reg ion, 111–112 nasofrontal angle with ultrasound correlation,
153–155, 153 –155 non-melanoma skin cancer (NMSC), 64, 65 non-surgical proleplasty, 115–118, 116, see
also clinical cases
inje ctable, 115–116 introduction, 115 surgical proleplasty, and, 116–118
non-surgical rhinoplasty, 85–101, see also
clinical cases
ethnic features, 86–87, 86–87 practical approaches, 87–101, 87–100
alar retraction or collapse, 97 assessment, 88 bunny lines, 100 closed nasal labial angle nasal base
retrusion, 90
crooked nose deformity, 96 deep glabella, 94 dependent tip, 91 deviated nose, 95
hidden columella nasal base
retrusion, 89 injection plan and procedure, 97–99 nasal base retrusion, 89 nasal hump, 92 overprojected nose, 94 results, 100 saddle nose, 93 sagging nasal tip, 100 secondary defects, 96 statistical analysis on treated patients
and stability of ller, 100 introduction, 85–86 nasal boundaries, 87, 87 posttreatment, 101
O
OC T, see optical coherence tomography optical “camouage,” 147 optical coherence tomography (OCT), 69
acne, and, 71 lichen planus, and, 74 psoriasis, and, 74 seborrheic dermatitis, and, 72–73
overprojected nose, 94
P
patient consultation, 45–46, 45
MD Codes, 46–47, 47
patient preparation, 39 perioral dermatitis, 61, 61 picture protocol, 40, 40–44 platyrrhine nose, 86, 86 points
lines identifying specic points, 24, 24
posttreatment, 101 preoperative diagnosis and assessment,
51–75, 88 endoscopic diagnosis and instrumentation
tools, 54 introduction, 51 magnetic resonance imaging (MRI),
52–53, 52 –53 other techniques, 55 skin conditions affecting the nose and
perinasal area, 57–67
acne, 59–60, 59– 60, 61, 71–72 autoimmune diseases, 75 basal cell carcinoma, (BCC),
64–66, 65
conditions mandating pretreatment
before ller procedures, 58
dermatitis, 62, 62 brous papule (FP), 63, 63 herpes simplex virus (HSV), 58, 59,
70–71
impetigo, 59, 72 infective/inammatory conditions, 58 introduction, 57–58, 58 lichen planus, 73–74 lupus, 74 malignant melanoma (MM), 66–66 non-melanoma skin cancer (NMSC),
64, 65
perioral dermatitis (POD), 61, 61 psoriasis, 73–74, 74 rosacea 60–61, 60, 61, 70 scleroderma, 75 sebaceous hyperplasia (SH), 63 seborrheic dermatitis (SD), 63, 72–73 seborrheic keratoses (SK), 63–64, 64
tools, 69–75
computed tomography (CT), 75 dermoscopy, 69–74 line-eld confocal optical coherence
tomography (LC-OCT), 69, 71
optical coherence tomography (OCT),
69, 71–74
reectance confocal microscopy
(RCM), 69–75
speckle-variance OCT (dynamic OCT;
D-OCT), 69–70
ultrasound techniques, 53–54, 53 preparation, patient, 39 prevention of severe complications, 122–124 proleplasty, see non-surgical proleplasty protocol, picture, 40, 40–44 psoriasis, 73
dermoscopy, and, 73
OCT, and, 74
RCM, and, 74
R
RCM, see reectance confocal microscopy reectance confocal microscopy (RCM),
rhino 4-point technique with llers of different
rhinoplasty, see non-surgical rhinoplasty;
rosacea, 60–61, 60, 61, 70
69–70 acne, and, 71 autoimmune diseases, 75 impetigo, and, 72 lichen planus, and, 74 psoriasis, and, 74 rosacea, and, 70 seborrheic dermatitis, and, 73
densities,
surgical rhinoplasty
dermoscopy, and, 70 D-OCT, and, 70 RCM, and, 70
149–152, 150 –151
S
saddle nose, 93 sagging nasal tip
botulinum toxin, 8, 100
sebaceous hyperplasia, 63 seborrheic dermatitis (SD), 63, 72–73
dermoscopy, and, 72 OCT, and, 72–73 RCM, and, 73
seborrheic keratoses (SK), 63–64, 64 secondary defects, 96 skin, 27, 27 skin conditions affecting the nose and
perinasal area, 57–67 acne, 59–60, 59– 60, 61, 71–72 autoimmune diseases, 75
INDEX 155
basal cell carcinoma, (BCC), 64–66, 65 conditions mandating pretreatment before
ller procedures, 58 dermatitis, 62, 62 brous papule (FP), 63, 63 herpes simplex virus (HSV), 58, 59, 70–71 impetigo, 59, 72 infective/inammatory conditions, 58 introduction, 57–58, 58 lichen planus, 73–74 lupus, 74 malignant melanoma (MM), 66–66 non-melanoma skin cancer (NMSC), 64, 65 perioral dermatitis (POD), 61, 61 psoriasis, 73–74, 74 rosacea 60–61, 60, 61, 70 scleroderma, 75 sebaceous hyperplasia (SH), 63 seborrheic dermatitis (SD), 63, 72–73 seborrheic keratoses (SK), 63–64, 64
Slavic cases, 147–148, 14 7–148 social networks
impact of, 15–17
speckle-variance OCT (dynamic OCT;
D-OCT), 69 rosacea, and, 70
stability of ller, 100 statistical analysis on treated patients and
surface anatomy, 21–24
surgical proleplasty, 116–118 surgical rhinoplasty, 79–84
surrounding areas, nasal, 23, 23,
stability of ller, 100
introduction, 21 lines identifying specic points, 24, 24 nasal grid, 24, 24 nasal surrounding areas, 23, 23 nasal terminology, 21–23, 22
clinical case, 82–84, 82–84 surgical technique, 79–82, 80–
109– 113, 109 cheek and zygomatic arch 110–111 introduction, 109 lips, 112–113 na solabial reg ion, 111–112 Slavic cases, 147
82
T
technical approach, see clinical defects and
technical devices
the technical approach
introduction to, 35–39, 36–38 technique, surgical 79–82, 80–82 terminology, nasal, 21–23, 22 therapy of complications, 125–127
late occurring reactions, 126–127 vascular complications, 125–126
tinkerbell tip lift technique, 157–159,
158 –159
treatments, see nasal aesthetic treatments
U
ultrasound techniques, 53–54, 53
nasofrontal angle with ultrasound
correlation, 153–155,
153–155
V
vascular complications, 125–126, see also
complications
vascularization, 29, 29
Z
zygomatic arch 110 –111
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/